IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks

Range Low Price High Price Comment
30 days $143.66 $159.34 Monday, 15th Apr 2024 ALNY stock ended at $147.70. This is 0.539% less than the trading day before Friday, 12th Apr 2024. During the day the stock fluctuated 2.48% from a day low at $146.73 to a day high of $150.37.
90 days $143.52 $192.05
52 weeks $143.52 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2021-02-08 $165.46 $169.93 $162.25 $165.15 494 463
2021-02-05 $158.42 $167.70 $158.42 $165.11 613 293
2021-02-04 $152.80 $162.00 $152.36 $157.91 878 357
2021-02-03 $154.09 $157.27 $149.99 $151.25 812 382
2021-02-02 $149.92 $154.15 $148.32 $154.05 998 563
2021-02-01 $154.65 $156.62 $146.90 $149.25 816 162
2021-01-29 $154.63 $156.67 $148.31 $150.48 931 732
2021-01-28 $157.50 $157.50 $149.63 $154.74 825 695
2021-01-27 $168.58 $168.89 $152.51 $155.39 1 248 799
2021-01-26 $174.15 $178.41 $169.16 $170.02 538 202
2021-01-25 $170.43 $176.78 $168.15 $175.69 1 157 898
2021-01-22 $165.78 $173.20 $163.90 $172.38 534 530
2021-01-21 $172.54 $172.61 $166.35 $166.75 543 691
2021-01-20 $169.65 $173.00 $167.01 $170.97 1 025 793
2021-01-19 $167.88 $171.00 $167.02 $168.41 637 866
2021-01-15 $165.35 $171.01 $165.35 $166.36 704 310
2021-01-14 $169.78 $169.78 $164.02 $165.07 1 279 958
2021-01-13 $165.65 $175.41 $163.95 $170.93 2 388 463
2021-01-12 $156.03 $165.91 $156.03 $165.65 1 550 933
2021-01-11 $148.56 $157.39 $146.42 $156.63 1 306 350
2021-01-08 $138.73 $147.00 $137.72 $146.66 807 931
2021-01-07 $133.62 $140.00 $132.03 $139.40 1 072 128
2021-01-06 $126.33 $128.13 $125.38 $126.83 758 132
2021-01-05 $125.56 $127.70 $124.00 $127.45 496 517
2021-01-04 $130.69 $132.78 $126.94 $128.10 527 407
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT